Loading…
Human Growth Hormone Restriction Act of 2007
Legislative Progress
Introduced
December 19, 2007
Latest Action
January 14, 2008
Primary Sponsor
Stephen F. LynchDemocratic(MA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
67pct
26d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · second_quarter · Health Issues
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Drug Safety Cont... Heparin Contamination Counterfeit Drugs FDA Globalization Act of 2008 H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 Stem Cell Research Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Human Growth Hormone Regulation S.877 H.R. 4911 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Outpatient Prospective Patient Services S. 3101: Medicare Improvements for Patients and Providers Act of 2008 In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) FY 2008 Supplemental Appropriations Bill (H.R. 2642) Access to Investigation Drugs for Seriously Ill Patents The Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (S.1956) Physician Payments Sunshine Act S.2029 Access to Drug Pricing Data H.R. 5683 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FDA Debarment H.R. 6378: The Strengthening of FDA Integrity Act Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations
Client expense: $1,920,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2008 · second_quarter · Law Enforcement/Crime/Criminal Justice
Human Growth Hormone Regulation S.877 H.R. 4911
Client expense: $1,920,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2008 · fourth_quarter · Pharmacy
Pharmacy Issues related to the sale of food and drugs, drug safety and drug abuse, repackaging of prescription drugs, medication guides and credit card fees for pharmacies. HR 5839, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs. HR 3610, Food and Drug Import Safety Act of 2007 HR 4911, Human Growth Hormone Restriction Act of 2007 S 877, Controlling the Abuse of Prescriptions Act of 2007 S 654, Safe Food Act of 2007 HR 1148, Safe Food Act of 2007 HR 5904, Safe FEAST Act of 2008 HR 5546, Credit Card Fair Fee Act
Client expense: $1,870,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008
Client expense: $3,250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Pharmacy
S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; DRUG IMPORTATION ASPECTS HR4911: HUMAN GROWTH HORMONE RESTRICTION ACT OF 2007; ALL PROVISIONS OF BILL HR1038: ACCESS TO LIFE SAVING MEDICINE ACT; FOLLOW-ON BIOLOGICS PROVISIONS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW ON BIOLOGICS HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL PROVISIONS OF BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW ON BIOLOGICS S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW ON BIOLOGICS S623: ACCESS TO LIFE-SAVING MEDICINE ACT; FOLLOW ON BIOLOGICS HR5839: SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF BILL HR6752/S3396: INDEPENDENT DRUG EDUCATION AND OUTREACH ACT OF 2008; ALL PROVISIONS OF BILL
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act H. R. 4911, Human Growth Hormone Restriction Act of 2007 S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
2008 · fourth_quarter · Homeland Security
Homeland Security (various Bills, Authorization, Appropriations) Passenger Cargo Screening S.1/H.R. 4911 Commission Recommendation Bill H.R. 5577, Chemical Plant Security
Client expense: $1,059,886 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Engraving & Printing, Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · fourth_quarter · Health Issues
**see addendum page Human Growth Hormone Regulation S. 877/H.R. 4911 - the Controlling the Abuse of Presciptions Act of 2007 Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicine Act of 2007 H.R. 1038 - Access to Life-Saving Medicine Act, Follow-On Biologics S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 5629 - the Pathway for Biosimilars Act S. 2029 - Physician Payments Sunshine Act of 2007, disclosure H.R. 5605 - Physician Payments Sunshine Act of 2008, disclosure H.R. 5683 - Government Accountability Office Act of 2008
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · fourth_quarter · Health Issues
State Children's Health Insurance Program (SCHIP) HR 3162/S.1893/HR 976 Veto Override Managed Care Reform Title VII, PHS act H.R. 2357/S. 2522 MediKids Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Medikids Health Insurance Act of 2007 Immunization Coding Issues Paul Wellstone Mental Health and Addiction Equity Act (HR 1424) Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records Emergency Medical Services for Children' Act Reauthorization Injury Prevention Child Health Care Crisis Relief Act s. 558 Mental Health Parity Act of 2007 Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Reauthorization of SCHIP S. 588 Resident Physician Shortage Reduction Act HR 3/S. 5 Stem Cell Research Enhancement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act HR 1153 Parental Right to Decide Protection Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 HR 1244/S. 600 School-Based Health Clinics Establishment Act HR 1198/S. 1069 Early Hearing and Detection and Intervention HR 1108/S. 625 Family Smoking Prevention and Tobacco Control Act FACT Act HR 2063/S.1232 Food Allergy and Anaphylaxis Act S. 877 Controlling the Abuse of Prescriptions Act of 2007 HR 4911 Human Growth Hormone Prescription Act HR 3411 Juvenile Crime Reduction Act HR 5178/S. 2451 First Step Forward Act HR 5178 Youth Reentry Improvement Act S. 2376 Medical Homes Act of 2007 HR 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 HR 5629 Pathway for Biosimilars Act HR 5613 Protecting the Medicaid Safety Net Act of 2008 E-Meds Act S. 1551, Comprehensive TB Elimination Act S. 2456, Influenza Vaccine Security Act Garrett Lee Smith Memorial Act Child and Adolescent Mental Health Resilience Act of 2007 Arthritis Prevention control and care act of 2007 Underage Drinking Prevention Act of 2007 Patient and Pharmacy Protection Act of 2007 Non-prescription Drug Modernization Act of 2007 Global Pediatric HIV/AIDS Prevention and Treatment Act HR 5268 S.2819 S. 2685,Truth in Cigarette Labeling Act of 2008 H.R. 6393,Quit Smoking for Life Act of 2008 H.R. 1553/S. 911,Conquer Childhood Cancer Act of 2007 H.Res. 1216,Radiological Safety Resolution S. 3020,Food and Drug Administration Accountability and Trasparency Act H.R. 6901, Meth Free Families and Communities Act H.R. 5605/S. 2029, Physician Payments Sunshine Act S. 3155, Juvenile Justice adn Delinquency Prevention Reauthorization Act of 2008 H.S. 5524/S. 2982, Reconnecting Homelss Youth Act of 2008 H.R. 6680, Community AIDS and Hepatitis Prevention Act Americans with Disabilities Act Underage Drinking National center on Health Statistics
2008 · third_quarter · Health Issues
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008
2008 · third_quarter · Health Issues
**see addendum page Human Growth Hormone Regulation S. 877/H.R. 4911 - the Controlling the Abuse of Prescriptions Act of 2007 Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicine Act of 2007 H.R. 1038 - Access to Life-Saving Medicine Act, Follow-On Biologics S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 5629 - the Pathway for Biosimilars Act S. 2029 - Physician Payments Sunshine Act of 2007, disclosure H.R. 5605 - Physician Payments Sunshine Act of 2008, disclosure H.R. 5683 - Government Accountability Office Act of 2008
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Health Issues
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008
2008 · third_quarter · Pharmacy
H.R. 1038, Acces to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act H.R. 4911, Human Growth Hormone Restriction Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Patent & Trademark Office (PTO), SENATE, White House Office
2008 · third_quarter · Pharmacy
Pharmacy Issues related to the sale of food and drugs, drug safety and drug abuse. HR 5839, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs. HR 3610, Food and Drug Import Safety Act of 2007 S. 2071, Combat Methamphetamine Enhancement Act of 2007 S. 1276, Methamphetamine Production Prevention Act of 2007 HR 4911, Human Growth Hormone Restriction Act of 2007 S 877, Controlling the Abuse of Prescriptions Act of 2007 S. 2274, Dextromethorphan Abuse Reduction Act of 2007 S. 654, Safe Food Act of 2007 H.R. 1148, Safe Food Act of 2007 HR 5904, Safe FEAST Act of 2008 S. 3666 and HR 6831, Copper Theft Prevention Act of 2008 HR 5546, Credit Card Fair Fee Act
Client expense: $1,316,532 · Firm income: Not reported
2008 · third_quarter · Homeland Security
Homeland Security (various Bills, authorization, appropriations) Passenger Cargo Screening S.1/H.R. 4911 Commission Recommendation Bill H.R. 5577, CHemical Plant Security
Client expense: $1,059,886 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Engraving & Printing, Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · third_quarter · Pharmacy
S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; DRUG IMPORTATION ASPECTS HR4911: HUMAN GROWTH HORMONE RESTRICTION ACT 2007; ALL PROVISIONS OF BILL HR1038: ACCESS TO LIFE SAVING MEDICINE ACT; FOLLOW-ON BIOLOGICS PROVISIONS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW ON BIOLOGICS HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL PROVISIONS OF BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW ON BIOLOGICS S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW ON BIOLOGICS S623: ACCESS TO LIFE-SAVING MEDICINE ACT; FOLLOW ON BIOLOGICS HR5839: SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF BILL HR6752/S3396: INDEPENDENT DRUG EDUCATION AND OUTREACH ACT OF 2008; ALL PROVISIONS OF BILL
Client expense: $490,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; DRUG IMPORTATION ASPECTS HR4911: HUMAN GROWTH HORMONE RESTRICTION ACT 2007; ALL PROVISIONS OF BILL HR1038: ACCESS TO LIFE SAVING MEDICINE ACT; FOLLOW-ON BIOLOGICS PROVISIONS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW ON BIOLOGICS HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL PROVISIONS OF BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW ON BIOLOGICS S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW ON BIOLOGICS S623: ACCESS TO LIFE-SAVING MEDICINE ACT; FOLLOW ON BIOLOGICS HR5839: SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF BILL HR6752/S3396: INDEPENDENT DRUG EDUCATION AND OUTREACH ACT OF 2008; ALL PROVISIONS OF BILL
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act H. R. 4911, Human Growth Hormone Restriction Act of 2007 S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act
Client expense: Not reported · Firm income: $60,000
2008 · third_quarter · Health Issues
State Children's Health Insurance Program (SCHIP) HR 3162/S.1893/HR 976 Veto Override Managed Care Reform Title VII, PHS act H.R. 2357/S. 2522 MediKids Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Medikids Health Insurance Act of 2007 Immunization Coding Issues Paul Wellstone Mental Health and Addiction Equity Act (HR 1424) Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records Emergency Medical Services for Children' Act Reauthorization Injury Prevention Child Health Care Crisis Relief Act s. 558 Mental Health Parity Act of 2007 Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Reauthorization of SCHIP S. 588 Resident Physician Shortage Reduction Act HR 3/S. 5 Stem Cell Research Enhancement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act HR 1153 Parental Right to Decide Protection Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 HR 1244/S. 600 School-Based Health Clinics Establishment Act HR 1198/S. 1069 Early Hearing and Detection and Intervention HR 1108/S. 625 Family Smoking Prevention and Tobacco Control Act FACT Act HR 2063/S.1232 Food Allergy and Anaphylaxis Act S. 877 Controlling the Abuse of Prescriptions Act of 2007 HR 4911 Human Growth Hormone Prescription Act HR 3411 Juvenile Crime Reduction Act HR 5178/S. 2451 First Step Forward Act HR 5178 Youth Reentry Improvement Act S. 2376 Medical Homes Act of 2007 HR 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 HR 5629 Pathway for Biosimilars Act HR 5613 Protecting the Medicaid Safety Net Act of 2008 E-Meds Act S. 1551, Comprehensive TB Elimination Act S. 2456, Influenza Vaccine Security Act Garrett Lee Smith Memorial Act Child and Adolescent Mental Health Resilience Act of 2007 Arthritis Prevention control and care act of 2007 Underage Drinking Prevention Act of 2007 Patient and Pharmacy Protection Act of 2007 Non-prescription Drug Modernization Act of 2007 Global Pediatric HIV/AIDS Prevention and Treatment Act HR 5268 S.2819 S. 2685,Truth in Cigarette Labeling Act of 2008 H.R. 6393,Quit Smoking for Life Act of 2008 H.R. 1553/S. 911,Conquer Childhood Cancer Act of 2007 H.Res. 1216,Radiological Safety Resolution S. 3020,Food and Drug Administration Accountability and Trasparency Act H.R. 6901, Meth Free Families and Communities Act H.R. 5605/S. 2029, Physician Payments Sunshine Act S. 3155, Juvenile Justice adn Delinquency Prevention Reauthorization Act of 2008 H.S. 5524/S. 2982, Reconnecting Homelss Youth Act of 2008 H.R. 6680, Community AIDS and Hepatitis Prevention Act
2008 · second_quarter · Law Enforcement/Crime/Criminal Justice
Human Growth Hormone Regulation S.877 H.R. 4911
Client expense: $1,920,000 · Firm income: Not reported
2008 · second_quarter · Health Issues
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Clinical Trial Registry and Results Databases Risk Management Plans Drug Safety Cont... Heparin Contamination Counterfeit Drugs FDA Globalization Act of 2008 H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008 H.R. 3610: The Food and Drug Import Safety Act of 2007 Stem Cell Research Medicaid Rebates H.R. 1424 H.R. 6331 H.R. 3162 H.R. 1367 S.3101 Medicaid/Medicare Packages Dual Proportionality Medicaid Rebates in Hospital Outpatient Setting CMS AMP Regulations Human Growth Hormone Regulation S.877 H.R. 4911 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Funding for Biomedical Advanced Research & Development Authority (BARDA) Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Outpatient Prospective Patient Services S. 3101: Medicare Improvements for Patients and Providers Act of 2008 In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 6331 S. 3101 Medicare/Medicaid Packages International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Alliance for Healthcare Competitiveness Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 FY 2008 Supplemental Appropriations Bill (H.R. 2642) Funding for the Food and Drug Administration Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) FY 2008 Supplemental Appropriations Bill (H.R. 2642) Access to Investigation Drugs for Seriously Ill Patents The Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (S.1956) Physician Payments Sunshine Act S.2029 Access to Drug Pricing Data H.R. 5683 Drug Importation Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 FDA Debarment H.R. 6378: The Strengthening of FDA Integrity Act Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World U.S. Government Positions in WTO, WHO Negotiations
2008 · second_quarter · Pharmacy
Pharmacy Issues related to the sale of food and drugs, drug safety and drug abuse. HR 5839, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.; HR 3610, Food and Drug Import Safety Act of 2007; S. 2071, Combat Methamphetamine Enhancement Act of 2007; S. 1276, Methamphetamine Production Prevention Act of 2007; HR 4911, Human Growth Hormone Restriction Act of 2007; S 877, Controlling the Abuse of Prescriptions Act of 2007; S. 2274, Dextromethorphan Abuse Reduction Act of 2007; S. 654, Safe Food Act of 2007 H.R. 1148, Safe Food Act of 2007 HR 5904 Safe FEAST Act of 2008
Client expense: $1,010,101 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2008 · second_quarter · Health Issues
Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008
Client expense: $3,060,000 · Firm income: Not reported
2008 · second_quarter · Pharmacy
S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; ALL PROVISIONS OF THE BILL HR4911: HUMAN GROWTH HORMONE RETRICTION ACT OF 2007; ALL PROVISIONS OF THE BILL DRUG IMPORTATION ISSUES HR1038/S623: ACCESS TO LIFE-SAVING MEDICINE ACT, FOLLOW-ON BIOLOGICS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW-ON BIOLOGICS PROVISIONS OF THE BILL HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL PROVISIONS OF THE BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW-ON BIOLOGICS PROVISION OF THE BILL S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW-ON BIOLOGICS PROVISION OF THE BILL S2029: PHYSICIAN PAYMENTS SUNSHINE ACT OF 2007; ALL PROVISIONS OF THE BILL HR5839: THE SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF THE BILL DRUG IMPORT SAFETY DRAFT
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
2008 · second_quarter · Health Issues
**see addendum page Human Growth Hormone Regulation S. 877/H.R. 4911 - "the Controlling the Abuse of Prescriptions Act of 2007" Biosimilars H.R. 1956 - " Patient Protection and Innovative Biologic Medicine Act of 2007" H.R. 1038 - "Access to Life-Saving Medicine Act, Follow-On Biologics" S. 1695 - "Biologics Price Competition and Innovation Act of 2007" H.R. 5629 - "the Pathway for Biosimilars Act" S. 2029 - "Physician Payments Sunshine Act of 2007, disclosure" H.R. 5605 - "Physician Payment Sunshine Act of 2008, disclosure"
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act H. R. 4911, Human Growth Hormone Restriction Act of 2007 S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act
Client expense: Not reported · Firm income: $60,000
2008 · second_quarter · Homeland Security
Homeland Security (various Bills, authorization, appropriations) Passenger Cargo Screening S. 1/H.R. 4911 Commission Recommendation Bill H.R. 5577, Chemical Plant Security
Client expense: $1,312,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Engraving & Printing, Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · second_quarter · Pharmacy
H.R. 1038, Acces to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act H.R. 4911, Human Growth Hormone Restriction Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007
Client expense: $562,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · second_quarter · Health Issues
State Children's Health Insurance Program (SCHIP) HR 3162/S.1893/HR 976 Veto Override Managed Care Reform Title VII, PHS act H.R. 2357/S. 2522 MediKids Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Medikids Health Insurance Act of 2007 Immunization Coding Issues Paul Wellstone Mental Health and Addiction Equity Act (HR 1424) Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records Emergency Medical Services for Children' Act Reauthorization Injury Prevention Child Health Care Crisis Relief Act s. 558 Mental Health Parity Act of 2007 Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Reauthorization of SCHIP S. 588 Resident Physician Shortage Reduction Act HR 3/S. 5 Stem Cell Research Enhancement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act HR 1153 Parental Right to Decide Protection Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 HR 1244/S. 600 School-Based Health Clinics Establishment Act HR 1198/S. 1069 Early Hearing and Detection and Intervention HR 1108/S. 625 Family Smoking Prevention and Tobacco Control Act FACT Act HR 2063/S.1232 Food Allergy and Anaphylaxis Act HR 1881/S. 937 Expanding the Promise for Individuals w/ Autism Act S. 877 Controlling the Abuse of Prescriptions Act of 2007 HR 4911 Human Growth Hormone Prescription Act HR 3411 Juvenile Crime Reduction Act HR 5178/S. 2451 First Step Forward Act HR 5178 Youth Reentry Improvement Act S. 2376 Medical Homes Act of 2007 HR 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 HR 5629 Pathway for Biosimilars Act HR 5613 Protecting the Medicaid Safety Net Act of 2008 E-Meds Act S. 1551, Comprehensive TB Elimination Act S. 2456, Influenza Vaccine Security Act Garrett Lee Smith Memorial Act Child and Adolescent Mental Health Resilience Act of 2007 Arthritis Prevention control and care act of 2007 Underage Drinking Prevention Act of 2007 Patient and Pharmacy Protection Act of 2007 Non-prescription Drug Modernization Act of 2007 Global Pediatric HIV/AIDS Prevention and Treatment Act HR 5268 S.2819 S. 2685 Truth in Cigarette Labeling Act of 2008 H.R. 6393 Quit Smoking for Life Act of 2008 H.R. 1553/S. 911 Conquer Childhood Cancel Act of 2007 H.Res. 1216 Radiological Safety Resolution H.R. 3372 Emergency Contraception Education Act of 2007
2008 · first_quarter · Health Issues
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Heparin Contamination/Imported Drugs and Drug Products Counterfeit Drugs Drug Importation H.R. 3610 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Stem Cell Research S.5 Medicaid Rebates H.R. 1424 H. Con. Res. 312 S. Con. Res. 70 Senate Medicare Package Human Growth Hormone Abuse S. 877 H.R. 4911 340B of the Public Health Service Act/Drug Prices for Covered Entities H.R. 2606 S. 1376 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Biomedical Advanced Research & Development Authority (BARDA) Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Pandemic Influenza Preparedness Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Medicare Hospital Outpatient Drug Reimbursement Policies In Vitro Diagnostics Regulatory Oversight Critical Path Initiative Comparative Effectiveness Program Initiatives H.R. 3162 H. Con. Res. 312 S. Con. Res. 70 Medicare Packages Comparative Effectiveness Research Act of 2008 Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009
2008 · first_quarter · Law Enforcement/Crime/Criminal Justice
Human Growth Hormone Abuse S. 877 H.R. 4911
Client expense: $1,920,000 · Firm income: Not reported
2008 · first_quarter · Health Issues
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Heparin Contamination/Imported Drugs and Drug Products Counterfeit Drugs Drug Importation H.R. 3610 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Stem Cell Research S.5 Medicaid Rebates H.R. 1424 H. Con. Res. 312 S. Con. Res. 70 Senate Medicare Package Human Growth Hormone Abuse S. 877 H.R. 4911 340B of the Public Health Service Act/Drug Prices for Covered Entities H.R. 2606 S. 1376 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Biomedical Advanced Research & Development Authority (BARDA) Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Pandemic Influenza Preparedness Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Medicare Hospital Outpatient Drug Reimbursement Policies In Vitro Diagnostics Regulatory Oversight Critical Path Initiative Comparative Effectiveness Program Initiatives H.R. 3162 H. Con. Res. 312 S. Con. Res. 70 Medicare Packages Comparative Effectiveness Research Act of 2008 Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009
2008 · first_quarter · Law Enforcement/Crime/Criminal Justice
Human Growth Hormone Abuse S. 877 H.R. 4911
Client expense: $1,920,000 · Firm income: Not reported
2008 · first_quarter · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act H. R. 4911, Human Growth Hormone Restriction Act of 2007 S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007
Client expense: Not reported · Firm income: $60,000
2008 · first_quarter · Pharmacy
HR 5839, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.; HR 3610, Food and Drug Import Safety Act of 2007; S. 2071, Combat Methamphetamine Enhancement Act of 2007; S. 1276, Methamphetamine Production Prevention Act of 2007; HR 4911, Human Growth Hormone Restriction Act of 2007; S 877, Controlling the Abuse of Prescriptions Act of 2007; S. 2274, Dextromethorphan Abuse Reduction Act of 2007; S. 654, Safe Food Act of 2007
Client expense: $928,643 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · first_quarter · Pharmacy
HR 5839, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.; HR 3610, Food and Drug Import Safety Act of 2007; S. 2071, Combat Methamphetamine Enhancement Act of 2007; S. 1276, Methamphetamine Production Prevention Act of 2007; HR 4911, Human Growth Hormone Restriction Act of 2007; S 877, Controlling the Abuse of Prescriptions Act of 2007; S. 2274, Dextromethorphan Abuse Reduction Act of 2007; S. 654, Safe Food Act of 2007
Client expense: $928,643 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · first_quarter · Health Issues
*see addendum page Human Growth Hormone Abuse S. 877/H.R. 4911, the "Controlling the Abuse of Prescriptions Act of 2007" Stem Cell Research S. 5, the "Stem Cell Research Enhancement Act of 2007" Biosimilars H.R. 1956 - "Patient Protection and Innovative Biologic Medicine Act of 2007" H.R.1038 - "Access to Life-Saving Medicine Act, Follow-On Biologics" S. 1695 - "Biologics Price Competition and Innovation Act of 2007" H.R. 5629, the "Pathway for Biosimilars Act"
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · first_quarter · Law Enforcement/Crime/Criminal Justice
Human Growth Hormone Abuse S. 877 H.R. 4911
Client expense: $1,920,000 · Firm income: Not reported
2008 · first_quarter · Health Issues
Drug Safety Implementation of Food & Drug Administration Amendments Act of 2007 Heparin Contamination/Imported Drugs and Drug Products Counterfeit Drugs Drug Importation H.R. 3610 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Department of Homeland Security Appropriations Act for FY 2009 Stem Cell Research S.5 Medicaid Rebates H.R. 1424 H. Con. Res. 312 S. Con. Res. 70 Senate Medicare Package Human Growth Hormone Abuse S. 877 H.R. 4911 340B of the Public Health Service Act/Drug Prices for Covered Entities H.R. 2606 S. 1376 Follow-on Biologics H.R. 1038 H.R. 1956 H.R. 5629 S. 1695 FDA Regulatory Processes for First-Time Filers Biomedical Advanced Research & Development Authority (BARDA) Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Pandemic Influenza Preparedness Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Vaccine Financing National Vaccine Advisory Committee Draft Recommendations Vaccines for Children Program National Vaccine Advisory Committee Draft Recommendations Influenza Vaccine Supply and Immunization Recommendations Barriers and Incentives Related to Personalized Medicine Medicare Hospital Outpatient Drug Reimbursement Policies In Vitro Diagnostics Regulatory Oversight Critical Path Initiative Comparative Effectiveness Program Initiatives H.R. 3162 H. Con. Res. 312 S. Con. Res. 70 Medicare Packages Comparative Effectiveness Research Act of 2008 Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 International Market Access for U.S. Healthcare Products Healthcare Sector Advocacy/Free Trade Agreements Funding for National Institutes of Health Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009
2008 · first_quarter · Pharmacy
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price competition and Innovation Act of 207, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 877, Controlling Abuse of Prescription Drugs Act of 2007 H.r. 4911, Human Growth Hormone Restriction Act of 2007
Client expense: $591,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
2008 · first_quarter · Health Issues
State Children's Health Insurance Program (SCHIP) HR 3162/S.1893/HR 976 Veto Override Managed Care Reform Title VII, PHS act Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's Access to health insurance Immunizations WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Medikids Health Insurance Act of 2007 Immunization Coding Issues Paul Wellstone Mental Health and Addiction Equity Act (HR 1424) Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Heath Information Technology/Electronic Health Records Emergency Medical Services for Children' Act Reauthorization Injury Prevention Child Health Care Crisis Relief Act s. 558 Mental Health Parity Act of 2007 Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Reauthorization of SCHIP S. 588 Resident Physician Shortage Reduction Act HR 3/S. 5 Stem Cell Research Enhancement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Need Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act HR 1153 Parental Right to Decide Protection Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 HR 1244/S. 600 School-Based Health Clinics Establishment Act HR 1198/S. 1069 Early Hearing and Detection and Intervention HR 1108/S. 625 Family Smoking Prevention and Tobacco Control Act FACT Act HR 2063/S.1232 Food Allergy and Anaphylaxis Act HR 1881/S. 937 Expanding the Promise for Individuals w/ Autism Act S. 877 Controlling the Abuse of Prescriptions Act of 2007 HR 4911 Human Growth Hormone Prescription Act HR 3411 Juvenile Crime Reduction Act HR 5178/S. 2451 First Step Forward Act HR 5178 Youth Reentry Improvement Act S. 2376 Medical Homes Act of 2007 HR 5501 Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 HR 5629 Pathway for Biosimilars Act HR 5613 Protecting the Medicaid Soliety Net Act of 2008 E-Meds Act SCHIP Reauthorization Act S. 1551, Comprehensive TB Elimination Act S. 2456, Influenza Vaccine Security Act Garrett Lee Smith Memorial Act Child and Adolescent Mental Health Resilience Act of 2007 Arthritis Prevention control and care act of 2007 Underage Drinking Prevention Act of 2007 Patient and Pharmacy Protection Act of 2007 Non-prescription Drug Modernization Act of 2007 Global Pediatric HIV/AIDS Prevention and Treatment Act HR 5268 S.2819
Client expense: $65,846 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Client expense: $3,070,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Client expense: $3,060,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Client expense: $48,095 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $1,920,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Client expense: $57,402 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Client expense: $1,920,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $1,920,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $1,920,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $97,587 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Transportation, Dept of (DOT), Treasury, Dept of, White House Office